To include your compound in the COVID-19 Resource Center, submit it here.

BLU-554: Preliminary Ph I data

Preliminary data from 8 evaluable patients in an open-label, dose-escalation, international Phase I trial showed

Read the full 158 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE